1. Home
  2. RGNX vs CLDT Comparison

RGNX vs CLDT Comparison

Compare RGNX & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.04

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Logo Chatham Lodging Trust (REIT) of Beneficial Interest

CLDT

Chatham Lodging Trust (REIT) of Beneficial Interest

HOLD

Current Price

$13.44

Market Cap

597.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNX
CLDT
Founded
2008
2009
Country
United States
United States
Employees
N/A
16
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
528.6M
597.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RGNX
CLDT
Price
$8.04
$13.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$28.75
$11.00
AVG Volume (30 Days)
1.5M
427.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
4.13%
EPS Growth
18.08
N/A
EPS
N/A
N/A
Revenue
$10,393,000.00
N/A
Revenue This Year
$51.21
$2.94
Revenue Next Year
$19.08
N/A
P/E Ratio
N/A
$610.21
Revenue Growth
126.48
N/A
52 Week Low
$5.46
$6.08
52 Week High
$16.19
$13.48

Technical Indicators

Market Signals
Indicator
RGNX
CLDT
Relative Strength Index (RSI) 56.93 81.94
Support Level $5.67 $6.26
Resistance Level $9.88 N/A
Average True Range (ATR) 0.57 0.33
MACD 0.24 0.10
Stochastic Oscillator 67.37 95.68

Price Performance

Historical Comparison
RGNX
CLDT

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.

Share on Social Networks: